Fig. 1From: Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the SudanStudy profile. ETF early treatment failure, LCTF late clinical treatment failure, LPTF late parasitological treatment failure, ACPR adequate clinical and parasitological responseBack to article page